In re Carolyn J.S.

2024 IL App (3d) 220249-U
CourtAppellate Court of Illinois
DecidedMarch 13, 2024
Docket3-22-0249
StatusUnpublished
Cited by2 cases

This text of 2024 IL App (3d) 220249-U (In re Carolyn J.S.) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Carolyn J.S., 2024 IL App (3d) 220249-U (Ill. Ct. App. 2024).

Opinion

NOTICE: This order was filed under Supreme Court Rule 23 and is not precedent except in the limited circumstances allowed under Rule 23(e)(1).

2024 IL App (3d) 220249-U

Order filed March 13, 2024 ____________________________________________________________________________

IN THE

APPELLATE COURT OF ILLINOIS

THIRD DISTRICT

In re CAROLYN J.S., a Person Found ) Appeal from the Circuit Court Subject to Involuntary Medication, ) of the 18th Judicial Circuit, ) Du Page County, Illinois, (The People of the State of Illinois, ) ) Appeal No. 3-22-0249 Petitioner-Appellee, ) Circuit No. 22-MH-157 ) v. ) Honorable ) Craig R. Belford, Carolyn J.S., ) Judge, Presiding. ) Respondent-Appellant). ) ____________________________________________________________________________

JUSTICE DAVENPORT delivered the judgment of the court. Presiding Justice McDade and Justice Holdridge concurred in the judgment. ____________________________________________________________________________

ORDER

¶1 Held: We reverse the trial court’s involuntary medication order, accepting the State’s concession that its medication petition was facially deficient and respondent’s counsel was ineffective in failing to seek its dismissal.

¶2 Respondent, Carolyn J.S., challenges the trial court’s order finding her subject to the

involuntary administration of psychotropic medication under the Mental Health and Developmental Disabilities Code (Mental Health Code) (405 ILCS 5/1-100 et seq. (West 2022)).

For the following reasons, we reverse the trial court’s judgment.

¶3 I. BACKGROUND

¶4 At the time of these proceedings, respondent was 58 years old and a resident of Chicago.

In 2019, she was admitted to Illinois Masonic Medical Center in Chicago for mental health

treatment.

¶5 On March 22, 2022, the State petitioned for an order subjecting respondent to involuntary

administration of psychotropic medication. At the time, respondent was being held at Linden Oaks

Behavioral Health Center, where Dr. Walter Whang was primarily responsible for her care,

pending a hearing on the State’s earlier-filed petition for an order finding respondent subject to

involuntary admission. Dr. Whang prepared the medication petition on a form made available by

the Department of Human Services (Department). See Illinois Department of Human Services,

Petition for Administration of Psychotropic Medications/Electroconvulsive Therapy,

https://www.dhs.state.il.us/onenetlibrary/12/documents/Forms/IL462-2025.pdf (last visited

February 14, 2024). The petition set forth the reasons for Dr. Whang’s conclusion that respondent

was subject to involuntary medication:

“Patient with severe delusions and poor judgement, poor insight, poor impulse control.

Patient with severe psychosis cannot care for basic needs. Patient with severe suffering

believing she is being drugged, sexually assaulted, followed by a white man planning to

harvest her organs.”

¶6 The petition otherwise tracked the statutory language setting forth the seven requirements

for involuntary medication. See 405 ILCS 5/2-107.1(a-5)(4) (West 2022). The petition sought an

order permitting the facility to administer certain medications, listing Haldol as the “first choice”

2 and Risperdal, Ativan, and Cogentin as “alternatives.” The petition also asked that the facility be

allowed to perform a comprehensive metabolic profile, complete blood count, and an

electrocardiogram (EKG).

¶7 On the morning of March 23, the court entered an order, on the State’s motion, appointing

counsel for respondent in the medication proceedings and directing that respondent, her attorney,

and “all required persons” be given “[a]t least three *** days advance Notice of the time and place

of [the] hearing” on the petition. Contrary to the three-days’ notice provision, however, the

medication petition was set for hearing the next day, March 24. The next morning, respondent’s

attorney entered her appearance.

¶8 On March 23, the State also filed, without first asking for leave, an amended medication

petition. The amended petition added to Whang’s reasons for his conclusion, stating respondent

was a “potential danger to others secondary to her psychosis.” It also modified the proposed

medications, this time listing both Haldol and Risperdal Consta as “first choice[s].”

¶9 The trial court heard the medication petition on March 24. Before evidence was presented,

the court and the parties addressed preliminary matters. No one acknowledged the hearing was

taking place only two days after the petition was filed and only one day after the amended petition

was filed. See id. § 2-107.1(a-5)(1) (“The petitioner shall deliver a copy of [a medication] petition,

and notice of the time and place of the hearing, to the respondent *** no later than 3 days prior to

the date of the hearing” on the petition. (Emphasis added.)). Nor did anyone acknowledge the

amended petition failed to allege specific facts to support the statutory conclusions stated in the

petition.

¶ 10 During the hearing, Whang explained the proposed medication regimen. Whang identified

Risperdal Consta as the primary medication and Haldol, Ativan, and Cogentin as alternatives.

3 Whang explained that Risperdal Consta is a long-acting drug used to control psychosis. Risperdal

Consta sometimes does not provide an immediate benefit and thus an additional dose may be

needed one to two weeks later. Haldol is a fast-acting drug with effects similar to Risperdal Consta.

Haldol would be administered every four to eight hours and, if the facility observed “some decrease

in psychosis and lack of side effects, then [it] would switch to Risperdal Consta for the long-acting

drug.” This suggested Haldol and Risperdal would not be given concurrently. Ativan would be

given every four to six hours as needed to treat anxiety, aggression, and restlessness. Cogentin is

a “rapid response medication” for certain side effects associated with Risperdal Consta and Haldol,

and the facility would administer that medication every six hours as needed. With regard to the

requested testing—the metabolic profile, blood count, and EKG—Whang testified the tests were

“not necessary” to use the requested medications but he included them on the petition “for

completeness.”

¶ 11 At the conclusion of the hearing, the court found respondent subject to involuntary

medication and authorized the administration of the medication identified in the amended petition.

The written order did not conform exactly with Whang’s explanation of the proposed medication

regimen. It identified Risperdal Consta, Haldol, and Ativan as primary medications and did not

indicate that Haldol and Risperdal Consta would not be given concurrently. In addition, the order

authorized the requested testing as “essential tests and procedures.” Both the assistant state’s

attorney and respondent’s counsel signed the order, approving it “as to form.” The order was

limited to a 90-day duration.

¶ 12 The trial court denied respondent’s motion to reconsider, and this appeal followed.

¶ 13 II. ANALYSIS

4 ¶ 14 Respondent contends the medication order should be reversed because (1) the admission

order must also be reversed as it is predicated on an improperly entered admission order, and

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Amodeo v. Alamiri
2025 IL App (3d) 240472-U (Appellate Court of Illinois, 2025)
City of La Salle v. Hicks
2025 IL App (3d) 240351 (Appellate Court of Illinois, 2025)

Cite This Page — Counsel Stack

Bluebook (online)
2024 IL App (3d) 220249-U, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-carolyn-js-illappct-2024.